| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/03/2002 | WO2002000881A1 Bvdv virus-like particles |
| 01/03/2002 | WO2002000879A2 Methods for producing modified glycoproteins |
| 01/03/2002 | WO2002000876A1 Truncated egf receptor |
| 01/03/2002 | WO2002000873A1 Human site-1 protease promoter |
| 01/03/2002 | WO2002000871A2 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 01/03/2002 | WO2002000860A2 Novel proteases |
| 01/03/2002 | WO2002000856A2 Protein glycosylation modification in pichia pastoris |
| 01/03/2002 | WO2002000850A1 Method of preparing heart muscle cells and method of searching for remedy for heart diseases |
| 01/03/2002 | WO2002000849A1 Cell fraction containing cells capable of differentiating into nervous system cells |
| 01/03/2002 | WO2002000848A1 Dna/rna-embedding medium and method of use |
| 01/03/2002 | WO2002000847A2 Pluripotent embryonic stem (es) cell lines, improved methods for their production, and their use for germ line transmission and for the generation of genetically modified animals |
| 01/03/2002 | WO2002000840A2 Human lyases |
| 01/03/2002 | WO2002000838A2 Recombinant minimal catalytic vanadium haloperoxidases and their uses |
| 01/03/2002 | WO2002000730A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000727A2 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | WO2002000725A2 G-protein coupled receptor org10 |
| 01/03/2002 | WO2002000724A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | WO2002000721A2 Cytokine receptor zcytor17 |
| 01/03/2002 | WO2002000715A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
| 01/03/2002 | WO2002000692A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | WO2002000677A1 Nucleic acids, proteins, and antibodies |
| 01/03/2002 | WO2002000262A2 Modulation of chromosome function by chromatin remodeling agents |
| 01/03/2002 | WO2002000233A2 Purging of cells using viruses |
| 01/03/2002 | WO2002000174A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/03/2002 | WO2002000173A2 Methods for use of delivery composition for expanding, activating, committing or mobilizing one or more pluripotent, self-renewing and committed stem cells |
| 01/03/2002 | WO2002000171A2 Composition for delivery of hematopoietic growth factor |
| 01/03/2002 | WO2002000017A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5 |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001053461A9 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001046696A3 Methods and compositions for detecting hepatitis e virus |
| 01/03/2002 | WO2001045494A3 Pyrophosphatase stress-related proteins and methods of use in plants |
| 01/03/2002 | WO2001037884A3 Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| 01/03/2002 | WO2001036471A3 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 01/03/2002 | WO2001032843A3 Enhanced immune recognition of pathogenic cells by icsbp expression |
| 01/03/2002 | WO2000044915A9 Method for conveying bnyvv resistance to sugar beet plants |
| 01/03/2002 | US20020002714 Transgenic plants |
| 01/03/2002 | US20020002273 Rapamycin assay |
| 01/03/2002 | US20020002269 Artemin, a neurotrophic factor |
| 01/03/2002 | US20020001842 Cytoplasmic transfer to de-differentiate recipient cells |
| 01/03/2002 | US20020001841 Continuous t-cell lines |
| 01/03/2002 | US20020001840 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 01/03/2002 | US20020001831 Low cost manufacture of oligosaccharides |
| 01/03/2002 | US20020001826 Hematopoietic cells and methods based thereon |
| 01/03/2002 | US20020001824 Ligand-gated anion channels of insects |
| 01/03/2002 | US20020001798 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 01/03/2002 | US20020001626 Submucosa gel compositions |
| 01/03/2002 | US20020001586 Inhibiting proliferation of neural cells via contacting with antibody, antisense nucleotide, and/or polynucleotide that disrupts activity of granulin molecule |
| 01/03/2002 | US20020001580 Secreting products from skin by adeno-associated virus (AAV) gene transfer |
| 01/03/2002 | US20020001578 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs |
| 01/03/2002 | US20020001577 Use of cells with the ability to generate excitation within a cell preparation |
| 01/03/2002 | US20020001576 Medicaments containing allogenic activated-CD4+ cells as the main ingradient, which are attributable to an organ or bone marrow implant donor, have extreemly beneficial effect for preventing tumor and various infections |
| 01/03/2002 | CA2414485A1 Nutritional mixture and method for early identification and count of gram-negative organisms |
| 01/03/2002 | CA2414098A1 Human site-1 protease promoter |
| 01/03/2002 | CA2413910A1 Cell fractions containing cells capable of differentating into neural cells |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413683A1 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | CA2413596A1 Cell lines and cell-based assays for identification of androgen receptor modulators |
| 01/03/2002 | CA2413547A1 B7-like molecules and uses thereof |
| 01/03/2002 | CA2412701A1 Methods for producing modified glycoproteins |
| 01/03/2002 | CA2412637A1 Replication deficient adenoviral tnf vector |
| 01/03/2002 | CA2412635A1 Novel proteases |
| 01/03/2002 | CA2412621A1 Rescue of canine distemper virus from cdna |
| 01/03/2002 | CA2412610A1 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | CA2412256A1 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | CA2412239A1 Cytokine receptor zcytor17 |
| 01/03/2002 | CA2412211A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2410159A1 Heterologous gene expression in plants |
| 01/03/2002 | CA2409408A1 Modulation of chromosome function by chromatin remodeling agents |
| 01/03/2002 | CA2408326A1 Recombinant constructs and their use in reducing gene expression |
| 01/03/2002 | CA2381338A1 Human lyases |
| 01/03/2002 | CA2381241A1 Truncated egf receptor |
| 01/02/2002 | EP1167972A2 Enzyme catalyzed therapeutic agents |
| 01/02/2002 | EP1167533A1 Methods and means for the complementation of viral protein expression in stable cell lines |
| 01/02/2002 | EP1167532A2 Edible transgenic plants expressing mammalian proteins |
| 01/02/2002 | EP1167526A1 IgE-dependent histamine-releasing factor(HRF)receptor, HRF-binding peptides and nucleic acids encoding the same, and uses thereof |
| 01/02/2002 | EP1167519A1 Glucose dehydrogenase |
| 01/02/2002 | EP1167518A1 Method for selectively separating blood cells by using lectin |
| 01/02/2002 | EP1167517A1 Tissue engineering |
| 01/02/2002 | EP1167389A1 Antibodies against the protein SEMP1, methods for their production and uses thereof |
| 01/02/2002 | EP1167386A1 Canine and feline melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 01/02/2002 | EP1167385A2 Human follicle stimulating hormone receptor |
| 01/02/2002 | EP1166112A1 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same |
| 01/02/2002 | EP1165836A2 Schizophrenia associated genes, proteins and biallelic markers |
| 01/02/2002 | EP1165830A1 Adipose-derived stem cells and lattices |
| 01/02/2002 | EP1165828A1 50 human secreted proteins |
| 01/02/2002 | EP1165827A1 45 human secreted proteins |
| 01/02/2002 | EP1165819A2 Delivery of functional protein sequences by translocating polypeptides |
| 01/02/2002 | EP1165818A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes |
| 01/02/2002 | EP1165816A2 Insect viral vectors and uses thereof |
| 01/02/2002 | EP1165815A1 Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 01/02/2002 | EP1165809A2 Leukotriene b4 receptor transgenic mammals |
| 01/02/2002 | EP1165805A1 Dsp-2 dual-specificity map kinase phosphatase |
| 01/02/2002 | EP1165803A2 Enzymes of the biosynthetic pathway for the production of triacylglycerol and recombinant dna molecules encoding these enzymes |
| 01/02/2002 | EP1165798A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope |